Prevalence, T2-biomarkers and cost of severe asthma in the era of biologics: The BRAVO-1 study. Domingo C, Sicras-Mainar A, Sicras-Navarro A, Sogo A, et al. J Investig Allergol Clin Immunol 2022 Nov 22:0. doi: 10.18176/jiaci.0871.

Read + Share

Amedeo Smart

Independent Medical Education

Domingo C, Sicras-Mainar A, Sicras-Navarro A, Sogo A, et al. Prevalence, T2-biomarkers and cost of severe asthma in the era of biologics: The BRAVO-1 study. J Investig Allergol Clin Immunol 2022 Nov 22:0. doi: 10.18176/jiaci.0871.
PMID: 36420740